Loading…
Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid β peptide levels
Recent epidemiological and clinical data suggest that elevated serum homocysteine levels may increase the risk of developing Alzheimer's disease (AD), but the underlying mechanisms are unknown. We tested the hypothesis that high serum homocysteine concentration may increase amyloid beta-peptide...
Saved in:
Published in: | Neurobiology of disease 2006-06, Vol.22 (3), p.651-656 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c448t-6ac078733677238a4d10aa0b8a8f4bd5005ff9f01f5ffbe40acdc23dc093fc313 |
---|---|
cites | cdi_FETCH-LOGICAL-c448t-6ac078733677238a4d10aa0b8a8f4bd5005ff9f01f5ffbe40acdc23dc093fc313 |
container_end_page | 656 |
container_issue | 3 |
container_start_page | 651 |
container_title | Neurobiology of disease |
container_volume | 22 |
creator | Pacheco-Quinto, Javier Rodriguez de Turco, Elena B. DeRosa, Steven Howard, Altovise Cruz-Sanchez, Felix Sambamurti, Kumar Refolo, Lorenzo Petanceska, Suzana Pappolla, Miguel A. |
description | Recent epidemiological and clinical data suggest that elevated serum homocysteine levels may increase the risk of developing Alzheimer's disease (AD), but the underlying mechanisms are unknown. We tested the hypothesis that high serum homocysteine concentration may increase amyloid beta-peptide (Aβ) levels in the brain and could therefore accelerate AD neuropathology. For this purpose, we mated a hyperhomocysteinemic CBS
tm1Unc mouse carrying a heterozygous dominant mutation in cystathionine-beta-synthase (CBS*) with the APP*/PS1* mouse model of brain amyloidosis. The APP*/PS1*/CBS* mice showed significant elevations of serum homocysteine levels compared to the double transgenic APP*/PS1* model of amyloidosis. Results showed that female (but not male) APP*/PS1*/CBS* mice exhibited significant elevations of Aβ40 and Aβ42 levels in the brain. Correlations between homocysteine levels in serum and brain Aβ levels were statistically significant. No increases in beta secretase activity or evidence of neuronal cell loss in the hyperhomocysteinemic mice were found.
The causes of neuronal dysfunction and degeneration in AD are not fully understood, but increased production of Aβ seems to be of major importance. By unveiling a link between homocysteine and Aβ levels, these findings advance our understanding on the mechanisms involved in hyperhomocysteinemia as a risk factor for AD. |
doi_str_mv | 10.1016/j.nbd.2006.01.005 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_282f5459dc554f98b11b1f747eb62abc</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0969996106000076</els_id><doaj_id>oai_doaj_org_article_282f5459dc554f98b11b1f747eb62abc</doaj_id><sourcerecordid>68064958</sourcerecordid><originalsourceid>FETCH-LOGICAL-c448t-6ac078733677238a4d10aa0b8a8f4bd5005ff9f01f5ffbe40acdc23dc093fc313</originalsourceid><addsrcrecordid>eNqFkU2O1DAQhS0EYpqBA7BBXsEqwU5sxxar0QiYkUZiAxI7yz9l2k0SBzs9qDkWB-FMeOgGdrCpkkpfPdWrh9BTSlpKqHi5a2fr244Q0RLaEsLvoQ0lijeK9x_vow1RQjVKCXqGHpWyI4RSroaH6IwKTgWT3QZ9vjoskLdpSu5QVogzTNHhi_HbFuIE-UXBU9oXqNXDiFPAZjqMKfpUYsFlm74WHGeXwRTw2GYT598E_vEdL7Cs0QMe4RbG8hg9CGYs8OTUz9GHN6_fX141N-_eXl9e3DSOMbk2wjgyyKHvxTB0vTTMU2IMsdLIwKzn1WcIKhAaarfAiHHedb13RPXB9bQ_R9dHXZ_MTi85TiYfdDJR_xqk_EmbvEY3gu5kFzjjyjvOWVDSUmppGNgAVnTGuqr1_Ki15PRlD2XVUywOxtHMUB-jhSSCKS7_C1LFhOS8qyA9gi6nUjKEPxdSou9i1TtdY9V3sWpCdbVbd56dxPd2Av9345RjBV4dgfpmuI2QdXERZgc-ZnBrNR7_If8T4ey1dA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19468552</pqid></control><display><type>article</type><title>Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid β peptide levels</title><source>ScienceDirect®</source><creator>Pacheco-Quinto, Javier ; Rodriguez de Turco, Elena B. ; DeRosa, Steven ; Howard, Altovise ; Cruz-Sanchez, Felix ; Sambamurti, Kumar ; Refolo, Lorenzo ; Petanceska, Suzana ; Pappolla, Miguel A.</creator><creatorcontrib>Pacheco-Quinto, Javier ; Rodriguez de Turco, Elena B. ; DeRosa, Steven ; Howard, Altovise ; Cruz-Sanchez, Felix ; Sambamurti, Kumar ; Refolo, Lorenzo ; Petanceska, Suzana ; Pappolla, Miguel A.</creatorcontrib><description>Recent epidemiological and clinical data suggest that elevated serum homocysteine levels may increase the risk of developing Alzheimer's disease (AD), but the underlying mechanisms are unknown. We tested the hypothesis that high serum homocysteine concentration may increase amyloid beta-peptide (Aβ) levels in the brain and could therefore accelerate AD neuropathology. For this purpose, we mated a hyperhomocysteinemic CBS
tm1Unc mouse carrying a heterozygous dominant mutation in cystathionine-beta-synthase (CBS*) with the APP*/PS1* mouse model of brain amyloidosis. The APP*/PS1*/CBS* mice showed significant elevations of serum homocysteine levels compared to the double transgenic APP*/PS1* model of amyloidosis. Results showed that female (but not male) APP*/PS1*/CBS* mice exhibited significant elevations of Aβ40 and Aβ42 levels in the brain. Correlations between homocysteine levels in serum and brain Aβ levels were statistically significant. No increases in beta secretase activity or evidence of neuronal cell loss in the hyperhomocysteinemic mice were found.
The causes of neuronal dysfunction and degeneration in AD are not fully understood, but increased production of Aβ seems to be of major importance. By unveiling a link between homocysteine and Aβ levels, these findings advance our understanding on the mechanisms involved in hyperhomocysteinemia as a risk factor for AD.</description><identifier>ISSN: 0969-9961</identifier><identifier>EISSN: 1095-953X</identifier><identifier>DOI: 10.1016/j.nbd.2006.01.005</identifier><identifier>PMID: 16516482</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Alzheimer Disease - blood ; Alzheimer Disease - metabolism ; Alzheimer Disease - pathology ; Alzheimer's disease ; Amyloid beta-Peptides - metabolism ; Amyloidosis ; Amyloidosis - blood ; Amyloidosis - metabolism ; Amyloidosis - pathology ; Animals ; Aβ40 ; Aβ42 ; Blotting, Western ; Brain ; Brain - metabolism ; Brain - pathology ; Brain Chemistry - physiology ; Cell Count ; Cystathionine beta-Synthase - genetics ; Disease Models, Animal ; Female ; Homocysteine - blood ; Hyperhomocysteinemia ; Immunohistochemistry ; Male ; Mice ; Mice, Transgenic ; Mutation ; Neurons - pathology ; Polymerase Chain Reaction ; Sex Factors</subject><ispartof>Neurobiology of disease, 2006-06, Vol.22 (3), p.651-656</ispartof><rights>2006 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c448t-6ac078733677238a4d10aa0b8a8f4bd5005ff9f01f5ffbe40acdc23dc093fc313</citedby><cites>FETCH-LOGICAL-c448t-6ac078733677238a4d10aa0b8a8f4bd5005ff9f01f5ffbe40acdc23dc093fc313</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0969996106000076$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3549,27924,27925,45780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16516482$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pacheco-Quinto, Javier</creatorcontrib><creatorcontrib>Rodriguez de Turco, Elena B.</creatorcontrib><creatorcontrib>DeRosa, Steven</creatorcontrib><creatorcontrib>Howard, Altovise</creatorcontrib><creatorcontrib>Cruz-Sanchez, Felix</creatorcontrib><creatorcontrib>Sambamurti, Kumar</creatorcontrib><creatorcontrib>Refolo, Lorenzo</creatorcontrib><creatorcontrib>Petanceska, Suzana</creatorcontrib><creatorcontrib>Pappolla, Miguel A.</creatorcontrib><title>Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid β peptide levels</title><title>Neurobiology of disease</title><addtitle>Neurobiol Dis</addtitle><description>Recent epidemiological and clinical data suggest that elevated serum homocysteine levels may increase the risk of developing Alzheimer's disease (AD), but the underlying mechanisms are unknown. We tested the hypothesis that high serum homocysteine concentration may increase amyloid beta-peptide (Aβ) levels in the brain and could therefore accelerate AD neuropathology. For this purpose, we mated a hyperhomocysteinemic CBS
tm1Unc mouse carrying a heterozygous dominant mutation in cystathionine-beta-synthase (CBS*) with the APP*/PS1* mouse model of brain amyloidosis. The APP*/PS1*/CBS* mice showed significant elevations of serum homocysteine levels compared to the double transgenic APP*/PS1* model of amyloidosis. Results showed that female (but not male) APP*/PS1*/CBS* mice exhibited significant elevations of Aβ40 and Aβ42 levels in the brain. Correlations between homocysteine levels in serum and brain Aβ levels were statistically significant. No increases in beta secretase activity or evidence of neuronal cell loss in the hyperhomocysteinemic mice were found.
The causes of neuronal dysfunction and degeneration in AD are not fully understood, but increased production of Aβ seems to be of major importance. By unveiling a link between homocysteine and Aβ levels, these findings advance our understanding on the mechanisms involved in hyperhomocysteinemia as a risk factor for AD.</description><subject>Alzheimer Disease - blood</subject><subject>Alzheimer Disease - metabolism</subject><subject>Alzheimer Disease - pathology</subject><subject>Alzheimer's disease</subject><subject>Amyloid beta-Peptides - metabolism</subject><subject>Amyloidosis</subject><subject>Amyloidosis - blood</subject><subject>Amyloidosis - metabolism</subject><subject>Amyloidosis - pathology</subject><subject>Animals</subject><subject>Aβ40</subject><subject>Aβ42</subject><subject>Blotting, Western</subject><subject>Brain</subject><subject>Brain - metabolism</subject><subject>Brain - pathology</subject><subject>Brain Chemistry - physiology</subject><subject>Cell Count</subject><subject>Cystathionine beta-Synthase - genetics</subject><subject>Disease Models, Animal</subject><subject>Female</subject><subject>Homocysteine - blood</subject><subject>Hyperhomocysteinemia</subject><subject>Immunohistochemistry</subject><subject>Male</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><subject>Mutation</subject><subject>Neurons - pathology</subject><subject>Polymerase Chain Reaction</subject><subject>Sex Factors</subject><issn>0969-9961</issn><issn>1095-953X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNqFkU2O1DAQhS0EYpqBA7BBXsEqwU5sxxar0QiYkUZiAxI7yz9l2k0SBzs9qDkWB-FMeOgGdrCpkkpfPdWrh9BTSlpKqHi5a2fr244Q0RLaEsLvoQ0lijeK9x_vow1RQjVKCXqGHpWyI4RSroaH6IwKTgWT3QZ9vjoskLdpSu5QVogzTNHhi_HbFuIE-UXBU9oXqNXDiFPAZjqMKfpUYsFlm74WHGeXwRTw2GYT598E_vEdL7Cs0QMe4RbG8hg9CGYs8OTUz9GHN6_fX141N-_eXl9e3DSOMbk2wjgyyKHvxTB0vTTMU2IMsdLIwKzn1WcIKhAaarfAiHHedb13RPXB9bQ_R9dHXZ_MTi85TiYfdDJR_xqk_EmbvEY3gu5kFzjjyjvOWVDSUmppGNgAVnTGuqr1_Ki15PRlD2XVUywOxtHMUB-jhSSCKS7_C1LFhOS8qyA9gi6nUjKEPxdSou9i1TtdY9V3sWpCdbVbd56dxPd2Av9345RjBV4dgfpmuI2QdXERZgc-ZnBrNR7_If8T4ey1dA</recordid><startdate>20060601</startdate><enddate>20060601</enddate><creator>Pacheco-Quinto, Javier</creator><creator>Rodriguez de Turco, Elena B.</creator><creator>DeRosa, Steven</creator><creator>Howard, Altovise</creator><creator>Cruz-Sanchez, Felix</creator><creator>Sambamurti, Kumar</creator><creator>Refolo, Lorenzo</creator><creator>Petanceska, Suzana</creator><creator>Pappolla, Miguel A.</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope><scope>DOA</scope></search><sort><creationdate>20060601</creationdate><title>Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid β peptide levels</title><author>Pacheco-Quinto, Javier ; Rodriguez de Turco, Elena B. ; DeRosa, Steven ; Howard, Altovise ; Cruz-Sanchez, Felix ; Sambamurti, Kumar ; Refolo, Lorenzo ; Petanceska, Suzana ; Pappolla, Miguel A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c448t-6ac078733677238a4d10aa0b8a8f4bd5005ff9f01f5ffbe40acdc23dc093fc313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Alzheimer Disease - blood</topic><topic>Alzheimer Disease - metabolism</topic><topic>Alzheimer Disease - pathology</topic><topic>Alzheimer's disease</topic><topic>Amyloid beta-Peptides - metabolism</topic><topic>Amyloidosis</topic><topic>Amyloidosis - blood</topic><topic>Amyloidosis - metabolism</topic><topic>Amyloidosis - pathology</topic><topic>Animals</topic><topic>Aβ40</topic><topic>Aβ42</topic><topic>Blotting, Western</topic><topic>Brain</topic><topic>Brain - metabolism</topic><topic>Brain - pathology</topic><topic>Brain Chemistry - physiology</topic><topic>Cell Count</topic><topic>Cystathionine beta-Synthase - genetics</topic><topic>Disease Models, Animal</topic><topic>Female</topic><topic>Homocysteine - blood</topic><topic>Hyperhomocysteinemia</topic><topic>Immunohistochemistry</topic><topic>Male</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><topic>Mutation</topic><topic>Neurons - pathology</topic><topic>Polymerase Chain Reaction</topic><topic>Sex Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pacheco-Quinto, Javier</creatorcontrib><creatorcontrib>Rodriguez de Turco, Elena B.</creatorcontrib><creatorcontrib>DeRosa, Steven</creatorcontrib><creatorcontrib>Howard, Altovise</creatorcontrib><creatorcontrib>Cruz-Sanchez, Felix</creatorcontrib><creatorcontrib>Sambamurti, Kumar</creatorcontrib><creatorcontrib>Refolo, Lorenzo</creatorcontrib><creatorcontrib>Petanceska, Suzana</creatorcontrib><creatorcontrib>Pappolla, Miguel A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Neurobiology of disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pacheco-Quinto, Javier</au><au>Rodriguez de Turco, Elena B.</au><au>DeRosa, Steven</au><au>Howard, Altovise</au><au>Cruz-Sanchez, Felix</au><au>Sambamurti, Kumar</au><au>Refolo, Lorenzo</au><au>Petanceska, Suzana</au><au>Pappolla, Miguel A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid β peptide levels</atitle><jtitle>Neurobiology of disease</jtitle><addtitle>Neurobiol Dis</addtitle><date>2006-06-01</date><risdate>2006</risdate><volume>22</volume><issue>3</issue><spage>651</spage><epage>656</epage><pages>651-656</pages><issn>0969-9961</issn><eissn>1095-953X</eissn><abstract>Recent epidemiological and clinical data suggest that elevated serum homocysteine levels may increase the risk of developing Alzheimer's disease (AD), but the underlying mechanisms are unknown. We tested the hypothesis that high serum homocysteine concentration may increase amyloid beta-peptide (Aβ) levels in the brain and could therefore accelerate AD neuropathology. For this purpose, we mated a hyperhomocysteinemic CBS
tm1Unc mouse carrying a heterozygous dominant mutation in cystathionine-beta-synthase (CBS*) with the APP*/PS1* mouse model of brain amyloidosis. The APP*/PS1*/CBS* mice showed significant elevations of serum homocysteine levels compared to the double transgenic APP*/PS1* model of amyloidosis. Results showed that female (but not male) APP*/PS1*/CBS* mice exhibited significant elevations of Aβ40 and Aβ42 levels in the brain. Correlations between homocysteine levels in serum and brain Aβ levels were statistically significant. No increases in beta secretase activity or evidence of neuronal cell loss in the hyperhomocysteinemic mice were found.
The causes of neuronal dysfunction and degeneration in AD are not fully understood, but increased production of Aβ seems to be of major importance. By unveiling a link between homocysteine and Aβ levels, these findings advance our understanding on the mechanisms involved in hyperhomocysteinemia as a risk factor for AD.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>16516482</pmid><doi>10.1016/j.nbd.2006.01.005</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0969-9961 |
ispartof | Neurobiology of disease, 2006-06, Vol.22 (3), p.651-656 |
issn | 0969-9961 1095-953X |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_282f5459dc554f98b11b1f747eb62abc |
source | ScienceDirect® |
subjects | Alzheimer Disease - blood Alzheimer Disease - metabolism Alzheimer Disease - pathology Alzheimer's disease Amyloid beta-Peptides - metabolism Amyloidosis Amyloidosis - blood Amyloidosis - metabolism Amyloidosis - pathology Animals Aβ40 Aβ42 Blotting, Western Brain Brain - metabolism Brain - pathology Brain Chemistry - physiology Cell Count Cystathionine beta-Synthase - genetics Disease Models, Animal Female Homocysteine - blood Hyperhomocysteinemia Immunohistochemistry Male Mice Mice, Transgenic Mutation Neurons - pathology Polymerase Chain Reaction Sex Factors |
title | Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid β peptide levels |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T12%3A10%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hyperhomocysteinemic%20Alzheimer's%20mouse%20model%20of%20amyloidosis%20shows%20increased%20brain%20amyloid%20%CE%B2%20peptide%20levels&rft.jtitle=Neurobiology%20of%20disease&rft.au=Pacheco-Quinto,%20Javier&rft.date=2006-06-01&rft.volume=22&rft.issue=3&rft.spage=651&rft.epage=656&rft.pages=651-656&rft.issn=0969-9961&rft.eissn=1095-953X&rft_id=info:doi/10.1016/j.nbd.2006.01.005&rft_dat=%3Cproquest_doaj_%3E68064958%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c448t-6ac078733677238a4d10aa0b8a8f4bd5005ff9f01f5ffbe40acdc23dc093fc313%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=19468552&rft_id=info:pmid/16516482&rfr_iscdi=true |